What it's for (Indications)
- Lormetazepam is indicated for the short-term treatment of insomnia.
- This includes situations where the insomnia is severe, disabling, or is causing extreme distress to the patient, significantly impairing their daily functioning or quality of life.
- As a benzodiazepine hypnotic, its use should generally be limited to the shortest possible duration, typically ranging from a few days to a maximum of four weeks, including a gradual tapering off period.
- Prolonged use carries a significant risk of developing physical and psychological dependence, as well as tolerance.
- The decision to prescribe lormetazepam should be based on a thorough assessment of the patient's sleep difficulties and potential underlying causes, after non-pharmacological interventions have been considered or failed.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The recommended adult dose of lormetazepam for insomnia is typically 0.5 mg to 1 mg taken orally shortly before bedtime. In severe cases of insomnia, the dosage may be cautiously increased to a maximum of 2 mg, strictly under medical supervision. For elderly or debilitated patients, and those with hepatic or renal impairment, a lower starting dose of 0.5 mg is strongly advised to minimize the risk of excessive sedation, psychomotor impairment, and other adverse effects, given their potentially altered metabolism and increased sensitivity. The treatment duration should be as short as possible, generally not exceeding 2 to 4 weeks, including a gradual dose reduction phase to prevent withdrawal symptoms and rebound insomnia. Abrupt discontinuation, particularly after prolonged use, must be avoided. |
Safety & Warnings
Common Side Effects
- Lormetazepam can cause various dose-related and individual-sensitivity-related side effects.
- Common adverse reactions include residual daytime drowsiness, dizziness, lightheadedness, ataxia (impaired coordination), headache, and confusion, particularly in the elderly.
- Patients may experience anterograde amnesia, a temporary impairment of memory for events occurring after drug intake, especially with higher doses or inadequate sleep duration.
- Other reported effects include muscle weakness, gastrointestinal disturbances (nausea, constipation), blurred vision, and paradoxical reactions such as excitement, agitation, hallucinations, aggression, or worsened insomnia, which necessitate immediate discontinuation.
- Long-term use can lead to physical and psychological dependence, with withdrawal symptoms manifesting upon abrupt cessation, including anxiety, tremor, palpitations, and potentially seizures.
Serious Warnings
- Black Box Warning: **WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; AND PHYSICAL DEPENDENCE AND WITHDRAWAL REACTIONS** **Concomitant Use With Opioids:** Concomitant use of benzodiazepines, including lormetazepam, and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation. **Abuse, Misuse, and Addiction:** The use of benzodiazepines, including lormetazepam, exposes patients to the risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other drugs, including other benzodiazepines and opioids, and alcohol. Assess each patient's risk of abuse, misuse, and addiction prior to prescribing lormetazepam and monitor all patients receiving lormetazepam for the development of these behaviors or conditions. **Physical Dependence and Withdrawal Reactions:** Continued use of benzodiazepines, including lormetazepam, may lead to physical dependence. The risks of withdrawal reactions, including seizures, are increased with abrupt or rapid discontinuation. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue lormetazepam or reduce the dosage.
- Lormetazepam carries significant risks requiring careful consideration.
- There is a substantial risk of developing physical and psychological dependence, particularly with prolonged use or at higher doses.
- Abrupt cessation can lead to severe withdrawal symptoms, including rebound insomnia, anxiety, tremor, and in severe cases, seizures.
- Tolerance may develop, necessitating higher doses for the same effect.
- Patients must be warned about impaired cognitive and motor skills, affecting abilities like driving or operating machinery, due to its central nervous system depressant effects.
- Caution is paramount in elderly patients, who are more susceptible to adverse effects such as falls, prolonged sedation, and cognitive impairment.
- Respiratory depression can occur, making it hazardous for individuals with compromised respiratory function.
- Paradoxical reactions like agitation or aggression warrant immediate discontinuation.
- The potential for abuse and misuse also exists, especially in individuals with a history of substance abuse.
How it Works (Mechanism of Action)
Lormetazepam is a short-acting benzodiazepine that exerts its therapeutic effects primarily by enhancing the activity of gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the central nervous system (CNS). It achieves this by binding allosterically to specific benzodiazepine binding sites on the GABA-A receptor complex. This binding leads to a conformational change in the receptor, which in turn increases the frequency of chloride ion channel opening. The influx of chloride ions into the neuron causes hyperpolarization of the neuronal membrane, thereby reducing neuronal excitability and making it more resistant to excitation. This potentiation of GABAergic inhibition results in the anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant properties characteristic of benzodiazepines, effectively reducing neuronal activity responsible for insomnia symptoms.
Commercial Brands (Alternatives)
No other brands found for this formula.